Stay updated with breaking news from Hot line session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this episode of Don't Miss a Beat, hosts offer a breakdown of 3 trials of note from the upcoming ESC Congress 2023 and provide context around the recent announcement of topline results from the SELECT trial. ....
It s all exploratory, but asundexian given with antiplatelets showed safe nuanced potential against poststroke recurrent events and quashed circulating factor XIa after stenting for acute MI. ....